In 2024, the trade exchange (includes international purchases and sales) of Glycosides, Natural or Reproduced by Synthesis; their Salts, Ethers, Esters and other Derivatives (Exc. Rutoside "Routine" and its Derivatives) was US$49.9M.
In 2024, the states with the most international sales in Glycosides, Natural or Reproduced by Synthesis; their Salts, Ethers, Esters and other Derivatives (Exc. Rutoside "Routine" and its Derivatives) were Ciudad de México (US$1.11M), Estado de México (US$1M), and Jalisco (US$63.9k).
The states with the most international purchases in 2024 were Estado de México (US$17.1M), Ciudad de México (US$15.7M), Jalisco (US$6.1M), Nuevo León (US$2.89M), and Querétaro (US$2.52M).
In 2024, the main commercial destinations of Glycosides, Natural or Reproduced by Synthesis; their Salts, Ethers, Esters and other Derivatives (Exc. Rutoside "Routine" and its Derivatives) were Costa Rica (US$1.07M), United States (US$427k), Brazil (US$184k), Panama (US$101k), and Guatemala (US$99.8k).
The main commercial origins of Glycosides, Natural or Reproduced by Synthesis; their Salts, Ethers, Esters and other Derivatives (Exc. Rutoside "Routine" and its Derivatives) in 2024 were Spain (US$13.8M), China (US$12.1M), Malaysia (US$6.97M), France (US$5.66M), and South Korea (US$3.44M).
In the global context, the main exporting countries of Glycosides, Natural or Reproduced by Synthesis; their Salts, Ethers, Esters and other Derivatives (Exc. Rutoside "Routine" and its Derivatives) in 2022 were China (US$974M), France (US$161M), and Malaysia (US$86.9M). In the same year, the main importing countries of Glycosides, Natural or Reproduced by Synthesis; their Salts, Ethers, Esters and other Derivatives (Exc. Rutoside "Routine" and its Derivatives) were United States (US$418M), Hong Kong (US$158M), and India (US$122M).